Rankings
▼
Calendar
PTCT FY 2025 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
PTCT
PTC Therapeutics, Inc.
$6B
FY 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1.7B
+114.5% YoY
Gross Profit
$1.7B
95.9% margin
Operating Income
$857M
49.5% margin
Net Income
$683M
39.4% margin
EPS (Diluted)
$7.78
Cash Flow
Operating Cash Flow
$711M
Free Cash Flow
$702M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$2.9B
Total Liabilities
$3.1B
Stockholders' Equity
-$205M
Cash & Equivalents
$985M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.7B
$807M
+114.5%
Gross Profit
$1.7B
$749M
+121.4%
Operating Income
$857M
-$303M
+383.1%
Net Income
$683M
-$363M
+287.9%
← Q4 2024
All Quarters
Q1 2025 →